A preliminary discussion on an action plan to eradicate the rapidly spreading dengue cases and Chikungunya virus infections, ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

April 26, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France's national public health agency, the Haute Autorité ...

Six people have died from chikungunya on the French overseas department of Réunion Island since the start of the year, health ...

Valneva said it has been supplying Ixchiq to help the French government respond to a major outbreak of chikungunya in La ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) ...

the Haute Autorité de Santé (HAS), has updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ ® for the prevention of disease caused by the chikungunya virus ...

Chikungunya virus (CHIKV) is a mosquito-borne viral disease spread by the bites of infected Aedes mosquitoes which causes fever, severe joint and muscle pain, headache, nausea, fatigue and rash. Joint ...

Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...

Mosquitoes transmit dengue fever chikungunya and malaria but each disease has its own physiological consequences ...

They are among the first in Sweden to be vaccinated against the chikungunya virus - a vaccine that is the result of a ...